MARKET

FENC

FENC

Fennec Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.21
+0.03
+0.49%
Closed 16:00 01/21 EST
OPEN
6.01
PREV CLOSE
6.18
HIGH
6.39
LOW
6.01
VOLUME
67.48K
TURNOVER
--
52 WEEK HIGH
8.40
52 WEEK LOW
3.255
MARKET CAP
114.35M
P/E (TTM)
-10.1603
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FENC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

FENC News

  • The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
  • Benzinga.01/14 12:55
  • Is Fennec Pharmaceuticals Inc. (FENC) A Good Stock To Buy?
  • Insider Monkey.12/20/2019 23:21
  • Catalyst Focuses on Firdapse Label Expansion Amid Competition
  • Zacks.11/29/2019 14:39
  • Fennec Pharmaceuticals Inc. (FENC) Shares March Higher, Can It Continue?
  • Zacks.11/27/2019 14:22

More

Industry

Biotechnology & Medical Research
-0.74%
Pharmaceuticals & Medical Research
-0.40%

Hot Stocks

Name
Price
%Change

About FENC

Fennec Pharmaceuticals Inc., formerly Adherex Technologies Inc., is a biopharmaceutical company focused on cancer therapeutics. The Company's lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children. STS has been studied by cooperative groups in over two Phase III clinical studies of survival and reduction of ototoxicity, The Clinical Oncology Group Protocol ACCL0431 and SIOPEL 6. The Children's Oncology Group (COG) ACCL0431 protocol enrolled 20% childhood cancers typically treated with intensive cisplatin therapy for localized and disseminated disease, including hepatoblastoma, germ cell tumor, osteosarcoma, neuroblastoma and medulloblastoma. SIOPEL 6 enrolled only hepatoblastoma patients with localized tumors.
More

Webull offers Fennec Pharmaceuticals Inc (FENC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.